SEC Info - Hologic Inc. - ‘8-K/A’ for 5/2/24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K/A

(Amendment No. 1)

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) i May 2, 2024

i HOLOGIC, INC.

(Exact Name of Registrant as Specified in Its Charter)

DELAWARE

(State or Other Jurisdiction of Incorporation)

i 1-36214		i 04-2902449
(Commission File Number)		(I.R.S. Employer Identification No.)

i 250 Campus Drive, i Marlborough, i Massachusetts		i 01752
(Address of Principal Executive Offices)		(Zip Code)

( i 508) i 263-2900

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, $.01 par value	i HOLX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02

Results of Operations and Financial Condition.

On May 3, 2024, Hologic, Inc. updated its press release, originally issued on May 2, 2024 (the “Original Release”) announcing its financial results for the second quarter ended March 30, 2024. The Original Release inadvertently included a reference on page 3 to “guidance for the second quarter”; the updated press release attached hereto as Exhibit 99.1 reflects the correct reference to “guidance for the third quarter”. Other than this correction, no other changes have been made to the Original Release. A copy of the updated press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such a filing.

Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Updated press release dated May 2, 2024, of Hologic, Inc. announcing its financial results for the second quarter ended March 30, 2024.
104		Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 3, 2024	HOLOGIC, INC.

	By:	/s/ *Karleen M. Oberton*
		Karleen M. Oberton
		Chief Financial Officer

This ‘8-K/A’ Filing	Date	Other Filings

Filed on:	5/3/24	10-Q
For Period end:	5/2/24	8-K
	3/30/24	10-Q
		List all Filings

Hologic Inc. – ‘8-K/A’ for 5/2/24

On: Friday, 5/3/24, at 8:00am ET · For: 5/2/24 · Accession #: 1140361-24-24213 · File #: 1-36214

Previous ‘8-K’: ‘8-K’ on / for 5/2/24 · Latest ‘8-K’: This Filing

Amendment to Current Report — Form 8-K

Filing Table of Contents

‘8-K/A’ — Amendment to Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference